These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 14998498)

  • 21. A comparative study of tuberculosis patients initiated on ART and receiving different models of TB-HIV care.
    Schulz SA; Draper HR; Naidoo P
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1558-63. PubMed ID: 24200268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-infection with human immunodeficiency virus and tuberculosis.
    Elston JW; Thaker HK
    Indian J Dermatol Venereol Leprol; 2008; 74(3):194-9. PubMed ID: 18583782
    [No Abstract]   [Full Text] [Related]  

  • 23. Reversal of misfortunes.
    Cohen J
    Science; 2013 Feb; 339(6122):898-903. PubMed ID: 23430629
    [No Abstract]   [Full Text] [Related]  

  • 24. Integrating tuberculosis and HIV services in Africa.
    Coutinho A; Mermin J
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):702. PubMed ID: 18544190
    [No Abstract]   [Full Text] [Related]  

  • 25. Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis.
    Suthar AB; Klinkenberg E; Ramsay A; Garg N; Bennett R; Towle M; Sitienei J; Smyth C; Daniels C; Baggaley R; Gunneberg C; Williams B; Getahun H; van Gorkom J; Granich RM
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):430-6. PubMed ID: 22640510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport.
    Zachariah R; Harries AD; Manzi M; Gomani P; Teck R; Phillips M; Firmenich P
    PLoS One; 2006 Dec; 1(1):e121. PubMed ID: 17205125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005.
    Pozniak AL; Miller RF; Lipman MC; Freedman AR; Ormerod LP; Johnson MA; Collins S; Lucas SB;
    HIV Med; 2005 Jul; 6 Suppl 2():62-83. PubMed ID: 16011537
    [No Abstract]   [Full Text] [Related]  

  • 28. Contemporary treatment of tuberculosis in HIV prevalent countries in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Jun; 75(6):358-63. PubMed ID: 9803621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy.
    Granich R; Getahun H; Reid A; Raviglione M; De Cock KM
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):925-6. PubMed ID: 19723370
    [No Abstract]   [Full Text] [Related]  

  • 30. Tuberculosis and HIV infection: partners in human tragedy.
    Bartlett JG
    J Infect Dis; 2007 Aug; 196 Suppl 1():S124-5. PubMed ID: 17624821
    [No Abstract]   [Full Text] [Related]  

  • 31. Predicting the failure of 3 by 5.
    Harries AD
    Lancet; 2005 Jul 9-15; 366(9480):117. PubMed ID: 16005322
    [No Abstract]   [Full Text] [Related]  

  • 32. Association between tuberculosis treatment outcomes and the mobile antiretroviral therapy programme in Zambia.
    Miyano S; Dube C; Kayama N; Ishikawa N; Nozaki I; Syakantu G
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):540-5. PubMed ID: 23394080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study.
    Lester R; Hamilton R; Charalambous S; Dwadwa T; Chandler C; Churchyard GJ; Grant AD
    AIDS; 2010 Nov; 24 Suppl 5():S45-8. PubMed ID: 21079427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The real challenges for scaling up ART in sub-Saharan Africa.
    Van Damme W; Kober K; Laga M
    AIDS; 2006 Mar; 20(5):653-6. PubMed ID: 16514294
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection.
    El-Sony AI; Khamis AH; Enarson DA; Baraka O; Mustafa SA; Bjune G
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1058-66. PubMed ID: 12546113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings.
    Lawn SD; Ayles H; Egwaga S; Williams B; Mukadi YD; Santos Filho ED; Godfrey-Faussett P; Granich RM; Harries AD
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):287-95. PubMed ID: 21333094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of antituberculosis treatments at 18 months follow-up in TB-HIV co-infected patients on ART: a retrospective review of 166 cases.
    Chunpongthong P; Ko ZZ; Yeekian C; Luvira V; Pitisuttithum P
    J Med Assoc Thai; 2011 Jun; 94(6):664-70. PubMed ID: 21696073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management challenges in tuberculosis and HIV.
    Meintjes G
    S Afr Med J; 2014 Dec; 104(12):885. PubMed ID: 26042272
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of home-based and health centre-based DOT: perspectives of TB care providers and clients in an HIV-endemic area of Thailand.
    Ngamvithayapong J; Yanai H; Winkvist A; Saisorn S; Diwan V
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):741-5. PubMed ID: 11495265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.